332157480	332157480	CD	B-NP	O
|	|	NNP	I-NP	O
VH	VH	NNP	I-NP	O
|	|	VBD	B-VP	O
48963348	48963348	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8152120	8152120	CD	B-NP	O
|	|	CC	I-NP	O
8/23/2005	8/23/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/20/2005	6/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/10/2005	5/10/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
JULIAR	JULIAR	NN	I-NP	B-protein
,	,	,	O	O
ERNESTO	ERNESTO	NNP	B-NP	O
ARLIE	ARLIE	NNP	I-NP	O
486-91-73-4	486-91-73-4	CD	I-NP	O
Illinois	Illinois	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/12/05	6/12/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MEEMKEN	MEEMKEN	NN	B-NP	O
,	,	,	O	O
CALEB	CALEB	NNP	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Headache	Headache	NNP	I-NP	I-protein
ECASA	ECASA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
81	81	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
PHOSLO	PHOSLO	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CALCIUM	CALCIUM	NNP	I-NP	I-protein
ACETATE	ACETATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
667	667	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
and	and	CC	I-NP	O
Q5PM	Q5PM	NN	I-NP	B-protein
HEPARIN	HEPARIN	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
TID	TID	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	JJ	B-NP	O
REGLAN	REGLAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
2.5-5	2.5-5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
lower	low	JJR	B-NP	O
dose	dose	NN	I-NP	O
first	first	RB	B-ADVP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

Try	Try	VB	B-VP	O
remaining	remain	VBG	I-VP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
if	if	IN	B-SBAR	O
no	no	DT	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

SENNA	SENNA	NN	B-NP	O
TABLETS	TABLETS	VBZ	B-VP	O
2	2	CD	B-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

50	50	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
NEPHROCAPS	NEPHROCAPS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
NEPHRO-VIT	NEPHRO-VIT	NNP	I-NP	I-protein
RX	RX	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/19/05	11/19/05	CD	B-NP	O
by	by	IN	B-PP	O
THURRELL	THURRELL	NNP	B-NP	O
,	,	,	O	O
XAVIER	XAVIER	NNP	B-NP	O
W	W	NNP	I-NP	O
ELDON	ELDON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

PLAVIX	PLAVIX	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
CELEXA	CELEXA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CITALOPRAM	CITALOPRAM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NOVOLOG	NOVOLOG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC+HS	AC+HS	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
1500cc	1500cc	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Arcilla	Arcilla	NNP	I-NP	O
Please	Please	NNP	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
METHYLDOPA	METHYLDOPA	NN	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
PRAZOSIN	PRAZOSIN	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
;	;	:	O	O
CHF	CHF	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
RLE	RLE	NNP	I-NP	O
DVT	DVT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
calf	calf	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
ABDOMINAL	ABDOMINAL	NN	I-NP	O
PAIN	PAIN	NN	I-NP	O
EXT	EXT	NN	I-NP	O
HEMORRHOIDS	HEMORRHOIDS	NN	I-NP	O
MS	MS	NN	I-NP	O
CHEST	CHEST	NN	I-NP	O
PAIN	PAIN	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ccy	ccy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ESRD	ESRD	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
end	end	NN	I-NP	O
stage	stage	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Afib	Afib	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperchol	hyperchol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
vitiligo	vitiligo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
vitiligo	vitiligo	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
72	72	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
ESRD	ESRD	NNP	B-NP	O
x	x	SYM	B-VP	O
5	5	CD	B-NP	O
yrs	yr	NNS	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
worsening	worsen	VBG	B-VP	O
n/v/d	n/v/d	NN	B-NP	O
/	/	SYM	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
s/p	s/p	NN	I-NP	O
2	2	CD	B-NP	O
admissions	admission	NNS	I-NP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
month	month	NN	I-NP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
n/v/d	n/v/d	NN	B-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
stool	stool	NN	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
Abd	Abd	NN	I-NP	O
CT	CT	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
EGD	EGD	NN	B-NP	B-DNA
7/7	7/7	CD	I-NP	I-DNA
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
gastritis	gastritis	NN	I-NP	O
.	.	.	O	O

D/C	D/C	NN	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
1/7	1/7	CD	B-NP	O
and	and	CC	O	O
represented	represent	VBN	B-VP	O
with	with	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
-LRB-	-LRB-	HYPH	B-NP	O
pleuritic	pleuritic	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Sx	Sx	NN	B-NP	O
came	come	VBD	B-VP	O
on	on	RP	B-PRT	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
hour	hour	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CP	CP	NN	I-NP	B-protein
SOB	SOB	NN	I-NP	I-protein
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
hematochezia	hematochezia	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
hematemasis	hematemasis	NN	B-NP	O
,	,	,	O	O
coffegrounds	coffeground	NNS	B-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
ESRD	ESRD	NN	B-NP	O
x	x	CC	O	O
5	5	CD	B-NP	O
yrs	yr	NNS	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
3v	3v	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
EF	EF	NN	I-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hyperchol	Hyperchol	NN	B-NP	O
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	O
MRSA	MRSA	NN	I-NP	O
pna	pna	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CCY	CCY	NNP	I-NP	O
,	,	,	O	O
h/o	h/o	DT	B-NP	O
DVT	DVT	NNP	I-NP	O
10/10	10/10	CD	I-NP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
prazosin	prazosin	NN	B-NP	O
SocHx	SocHx	NNP	I-NP	O
:	:	:	O	O
from	from	IN	B-PP	O
Juan	Juan	NNP	B-NP	O
Nard	Nard	NNP	I-NP	O
Go	Go	NNP	I-NP	O
IN	IN	NNP	I-NP	O
ED	ED	NNP	I-NP	O
:	:	:	O	O
T95	T95	CD	B-NP	O
.8	.8	CD	I-NP	O
P90	P90	NN	I-NP	O
160/100	160/100	CD	B-NP	O
RR16	RR16	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
elvated	elvate	VBN	B-VP	O
BNP	BNP	NNP	B-NP	O
,	,	,	O	O
D-Dimer	D-Dimer	NNP	B-NP	O
648	648	CD	I-NP	O
.	.	.	O	O

EXAM	EXAM	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
OP	OP	NNP	B-NP	O
MMM	MMM	NNP	I-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
carotid	carotid	VBD	B-VP	O
Bruit	Bruit	NNP	B-NP	O
;	;	:	O	O
RRR	RRR	NN	B-NP	O
s1s2	s1s2	NN	I-NP	O
no	no	DT	B-NP	O
R/R/M	R/R/M	NN	I-NP	B-protein
;	;	:	O	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
1/2	1/2	CD	B-NP	O
way	way	NN	I-NP	O
up	up	RB	B-ADVP	O
;	;	:	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	B-ADJP	O
with	with	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
;	;	:	O	O
ext	ext	IN	B-PP	O
WWP	WWP	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
;	;	:	O	O
neuro	neuro	NN	B-NP	O
intact	intact	JJ	I-NP	O
LABS	LABS	NN	I-NP	B-protein
:	:	:	O	O
wbc	wbc	NN	B-NP	O
17.06	17.06	CD	I-NP	O
;	;	:	O	O
hct	hct	NN	B-NP	O
33.5	33.5	CD	I-NP	O
,	,	,	O	O
CE	CE	NNP	B-NP	B-protein
's	's	POS	B-NP	I-protein
negative	negative	JJ	I-NP	I-protein
x	x	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
LFT	LFT	NNP	B-NP	O
's	's	POS	B-NP	O
wnl	wnl	NN	I-NP	O
;	;	:	O	O
D-Dimer	D-Dimer	NN	B-NP	O
648	648	CD	I-NP	O
;	;	:	O	O
BNP	BNP	NN	B-NP	O
3900	3900	CD	I-NP	O
;	;	:	O	O
INR	INR	NN	B-NP	O
1.2	1.2	CD	B-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulm	cardiopulm	NN	I-NP	O
process	process	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
long	long	JJ	B-NP	O
QTc	QTc	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
IMP	IMP	NN	I-NP	O
:	:	:	O	O
72	72	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
MMP	MMP	NN	B-NP	B-protein
,	,	,	O	O
depression/FTT	depression/FTT	NN	B-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
pleuritic	pleuritic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	O	O
increase	increase	VB	B-VP	O
WBC	WBC	NNP	B-NP	O
.	.	.	O	O

FEN/RENAL	FEN/RENAL	NNP	B-NP	O
:	:	:	O	O
HD	HD	NN	B-NP	O
TuThSat	TuThSat	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
current	current	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

Renal	Renal	NNP	B-NP	O
will	will	MD	B-VP	O
plan	plan	VB	I-VP	O
to	to	TO	I-VP	O
remove	remove	VB	I-VP	O
more	more	JJR	B-NP	O
volume	volume	NN	I-NP	O
at	at	IN	B-PP	O
HD	HD	NN	B-NP	O
in	in	IN	B-PP	O
future	future	JJ	B-NP	O
given	give	VBN	I-NP	O
representation	representation	NN	I-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
repleted	replete	VBN	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Kept	Kept	NNP	B-NP	O
strict	strict	JJ	I-NP	O
I/O	I/O	NN	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
1500cc	1500cc	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
diabetic/cardiac	diabetic/cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
single	single	JJ	B-NP	O
dose	dose	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
on	on	IN	B-PP	O
non-dialysis	non-dialysis	JJ	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
:	:	:	O	O
?	?	.	O	O

gastorparesis	gastorparesis	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
reglan	reglan	NN	I-NP	O
per	per	IN	B-PP	O
prior	prior	JJ	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
doing	do	VBG	B-VP	O
well	well	RB	B-ADVP	O
from	from	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

Still	Still	RB	B-ADVP	O
consider	consider	VB	B-VP	O
gastric	gastric	JJ	B-NP	O
emptying	empty	VBG	I-NP	O
study	study	NN	I-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
studies	study	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Outpatient	Outpatient	JJ	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
guaiac	guaiac	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
spoke	speak	VBD	I-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	NNP	B-NP	O
i	i	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Continued	Continue	VBD	B-VP	O
current	current	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
prob	prob	NN	I-NP	O
ACS	ACS	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
readmission	readmission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
p	p	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
fluid	fluid	NN	I-NP	O
up	up	IN	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
needs	need	VBZ	B-VP	O
more	more	JJR	B-NP	O
fluid	fluid	NN	I-NP	O
off	off	RP	B-PRT	O
in	in	IN	B-PP	O
HD	HD	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
goal	goal	NN	B-NP	O
weight	weight	NN	I-NP	O
adjusted	adjust	VBN	B-VP	O
per	per	IN	B-PP	O
renal	renal	NN	B-NP	O
.	.	.	O	O

Did	Did	NN	B-NP	O
require	require	VBP	B-VP	O
single	single	JJ	B-NP	O
dose	dose	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
as	as	IN	B-SBAR	O
patient	patient	NN	B-NP	O
does	do	VBZ	B-VP	O
make	make	VB	I-VP	O
some	some	DT	B-NP	O
urine	urine	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	JJ	B-NP	O
r	r	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Run	Run	NNP	I-NP	O
of	of	IN	B-PP	O
aberrant	aberrant	JJ	B-NP	O
conduction	conduction	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
self	self	NN	I-NP	O
resolving	resolve	VBG	B-VP	O
.	.	.	O	O

Followed	Follow	VBN	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
events	event	NNS	I-NP	O
noted	note	VBN	B-VP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
Due	Due	JJ	B-ADJP	O
to	to	TO	B-PP	O
contrast	contrast	NN	B-NP	O
allergy	allergy	NN	I-NP	O
V/Q	V/Q	NN	I-NP	O
scan	scan	NN	I-NP	O
done	do	VBN	B-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
PE	PE	NN	B-NP	O
given	give	VBN	B-VP	O
pleuritic	pleuritic	JJ	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
WBC	WBC	NN	I-NP	B-protein
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

V/Q	V/Q	NN	B-NP	O
scan	scan	NN	I-NP	O
read	read	VBN	B-VP	O
as	as	IN	B-PP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rothschild	Rothschild	NNP	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
resolved	resolve	VBN	B-VP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
and	and	CC	I-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
excess	excess	JJ	B-NP	O
volume	volume	NN	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Continued	Continue	VBN	B-NP	O
glipizide	glipizide	NN	I-NP	O
and	and	CC	I-NP	O
novolog	novolog	NN	I-NP	O
.	.	.	O	O

Glipizide	Glipizide	NN	B-NP	O
changed	change	VBD	B-VP	O
to	to	TO	B-PP	O
Q5PM	Q5PM	NN	B-NP	O
given	give	VBN	B-VP	O
early	early	JJ	B-NP	O
morning	morning	NN	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
tighter	tight	JJR	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
Code	Code	NNP	I-NP	O
:	:	:	O	O
FULL	FULL	NNP	B-NP	O
Neuro/Psych/Social	Neuro/Psych/Social	NNP	I-NP	O
:	:	:	O	O
I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
spoken	speak	VBN	I-VP	O
with	with	IN	B-PP	O
Lafountaine	Lafountaine	NN	B-NP	O
,	,	,	O	O
spanish	spanish	VB	B-VP	O
social	social	JJ	B-NP	O
worker	worker	NN	I-NP	O
who	who	WP	B-NP	O
knows	know	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	I-NP	O
family	family	NN	I-NP	O
from	from	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
has	have	VBZ	B-VP	O
seen	see	VBN	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
per	per	IN	B-PP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
overlying	overlie	VBG	I-NP	O
secondary	secondary	JJ	I-NP	O
gain	gain	NN	I-NP	O
from	from	IN	B-PP	O
hospitalizations	hospitalization	NNS	B-NP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
depression	depression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
declined	decline	VBN	I-VP	O
medication	medication	NN	B-NP	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
clexa	clexa	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
medication	medication	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
increased	increase	VBN	I-VP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
per	per	IN	B-PP	O
PT	PT	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
give	give	VB	I-VP	O
time	time	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
situation	situation	NN	I-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
lives	life	NNS	I-NP	O
on	on	IN	B-PP	O
top	top	JJ	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
difficulty	difficulty	NN	B-NP	O
leaving	leave	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
housing	housing	NN	I-NP	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
Placement	Placement	NN	B-NP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
as	as	IN	B-PP	O
FTT	FTT	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
requires	require	VBZ	B-VP	O
rehabilitation	rehabilitation	NN	B-NP	O
as	as	IN	B-SBAR	O
PT	PT	NN	B-NP	O
finds	find	VBZ	B-VP	O
her	her	PRP	B-NP	O
below	below	IN	B-PP	O
functional	functional	JJ	B-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
that	that	WDT	B-NP	O
concern	concern	VBP	B-VP	O
you	you	PRP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
follow	follow	NN	B-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
seek	seek	VBP	B-VP	O
the	the	DT	B-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
you	you	PRP	B-NP	O
PCP	PCP	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
in	in	IN	B-PP	O
Celexa	Celexa	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Call	Call	VB	B-VP	O
you	you	PRP	B-NP	O
PCP	PCP	NN	B-NP	O
for	for	IN	B-PP	O
follow	follow	NN	B-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DIDIER	DIDIER	NNP	B-NP	O
,	,	,	O	O
JUNIOR	JUNIOR	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BV15	BV15	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/12/05	6/12/05	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
02	02	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

